Grant: Master's Award: Canada Graduate Scholarships
University of Manitoba
$17,500.00
Sex as a biological variable: Immunomodulatory mechanisms of Innate Defence Regulator (IDR) peptides in asthma
FY 2020-21
Summary
Asthma is the most common chronic respiratory disease, resulting in lung inflammation and narrowing of airways making it difficult to breathe. Nearly 3 million Canadians suffer from asthma, and around 15% of patients do not respond to available steroid therapies. Steroid-unresponsive patients with uncontrolled asthma represent the major burden of disease, and account for annual healthcare costs of around $2B in Canada. Steroid therapies can also increase the risk of lung infections, which makes asthma worse. Thus, there is urgent need to develop new therapies that can control steroid-unresponsive asthma without compromising patient's ability to resolve infections. Adult females experience greater disease severity, are more likely to develop steroid-unresponsiveness and have uncontrolled asthma than males. Such Sex-bias is largely ignored during drug development. It is necessary to consider sex-differences in response during development of new treatments. This study will focus on new molecules known as Innate Defence Regulator (IDR) peptides, which can control both inflammation and infection. We have shown that IDR peptides improve breathing capacity and control lung inflammation in an animal model of asthma. We have identified a lead IDR peptide that can control critical cellular processes linked to steroid unresponsiveness. This project will comprehensively examine the effects of our lead IDR peptide in both females and males concurrently, to define sex-related differences, using an animal model and human lung cells. This research will directly support the development of a new IDR peptide-based therapy for asthma. It is entirely possible that we will need to develop sex-specific treatment protocols to provide the most efficient care for asthma sufferers.
Department
Program
Master's Award: Canada Graduate Scholarships
Recipient
Location
Manitoba, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
449782
Name
Marshall Courtney
Region
Manitoba
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Sex as a biological variable: Immunomodulatory mechanisms of Innate Defence Regulator (IDR) peptides in asthma
Programtype2
Studentship Programs
Orgnameinp2
University of Manitoba
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Airway Inflammation; Animal Model; Asthma; Immunomodulation; Innate Defence Regulator Peptides
Abstract
Asthma is the most common chronic respiratory disease, resulting in lung inflammation and narrowing of airways making it difficult to breathe. Nearly 3 million Canadians suffer from asthma, and around 15% of patients do not respond to available steroid therapies. Steroid-unresponsive patients with uncontrolled asthma represent the major burden of disease, and account for annual healthcare costs of around $2B in Canada. Steroid therapies can also increase the risk of lung infections, which makes asthma worse. Thus, there is urgent need to develop new therapies that can control steroid-unresponsive asthma without compromising patient's ability to resolve infections. Adult females experience greater disease severity, are more likely to develop steroid-unresponsiveness and have uncontrolled asthma than males. Such Sex-bias is largely ignored during drug development. It is necessary to consider sex-differences in response during development of new treatments. This study will focus on new molecules known as Innate Defence Regulator (IDR) peptides, which can control both inflammation and infection. We have shown that IDR peptides improve breathing capacity and control lung inflammation in an animal model of asthma. We have identified a lead IDR peptide that can control critical cellular processes linked to steroid unresponsiveness. This project will comprehensively examine the effects of our lead IDR peptide in both females and males concurrently, to define sex-related differences, using an animal model and human lung cells. This research will directly support the development of a new IDR peptide-based therapy for asthma. It is entirely possible that we will need to develop sex-specific treatment protocols to provide the most efficient care for asthma sufferers.
Competitiondate
202012
Approvedterm2
1 yr 0 mth
Pinamesdelim
Marshall, Courtney
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~